Trump takes first step to return medical supply chains to U.S.

The Trump administration said it has awarded a $354 million contract to a Virginia start-up that will manufacture a variety of generic drugs and their ingredients — including medicines used to treat covid-19 — at advanced manufacturing facilities in the United States.